Malignant Solid Tumor
A malignant solid tumor is a type of cancer that forms a mass of abnormal cells in solid tissues, which can invade nearby structures and spread to other parts of the body.
Advanced Tumors: TILs Treatment Study
We are studying a new therapy using tumor-infiltrating lymphocytes for patients with advanced tumors that have specific genetic changes. The goal is to see if this treatment can improve survival and tumor response.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Do you have a solid tumor diagnosis, such as sarcoma or carcinoma, confirmed by a doctor?
- Have you had any cancer treatment in the last 21 days, including chemotherapy or immunotherapy?
- Are you currently taking steroids at a dose higher than 10 mg of prednisone per day?
- Do you have any active brain metastases or untreated brain tumors?
- Have you had another cancer in the last 3 years that required treatment?
What experimental substances are being tested?
Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.
Tumor Infiltrating Lymphocytes
What similar medicines might you know?
Don't worry if you don't know the medicines tested in the trial. There is a chance you have heard about the similar medicines. Check the list below to see if you are familiar with any of them.
Bendarabin
Beneflur
Cyclophosphamid Hexal
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Hospital Universitari Vall D Hebron
Oncology
Barcelona, Spain
Hospital Universitario Hm Sanchinarro
Oncology
Chamartín, Spain
Institut Catala D'oncologia
Oncology
L'Hospitalet de Llobregat, Spain
Sponsor: Fundacio Institut D Investigacio Biomedica De Bellvitge IDIBELL
Last updated: Nov 26, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.